Latest Posts
About This Stock
More About This Stock
Read
Read
Read
9 Monster Stock Market Predictions For The Week Of March 28
Article By:
Michael J. Kramer
Sunday, March 27, 2022 12:15 PM EDT
It will be a critical week for stocks after weeks of gains. The S&P 500 finished Friday in an exciting spot and at more than one inflection point. It may mark the start of a bigger run higher to the mid-4600's, or the beginning of the next leg down.
Bear Market Bets In Biotech
Article By:
MoneyShow.com
Monday, February 7, 2022 9:44 AM EDT
Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020.
9 Monster Stock Market And Earnings Predictions – Sunday, August 1
Article By:
Michael J. Kramer
Sunday, August 1, 2021 10:50 AM EDT
Stocks finished the week of July 30 lower, dropping by 40 bps and while the S&P 500 didn’t finish down all that much, we could wonder if last week served as a turning point for the market overall.
Key Catalysts For ACADIA Pharmaceuticals
What do you think specifically has helped $ACAD thrive during the Pandemic? While they are focusing on the development of drugs unrelated to COVID-19, how were they able to thrive?
Sunday Trio Of Short Ideas
100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.
I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.
$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.
Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.